EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MicroRNA-21 Emerges as Key Prognostic Indicator After Breast Cancer Surgery

Kağan Gökçe iD, Murat Üner, Nur Adil, Mehrdad Sheikhvatan iD

Journal of Clinical Medicine · 25.05.2026 · 15 (11) · 4053

DOI: 10.3390/jcm15114053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.05.2026. Verfasst von Kağan Gökçe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Oncology Unit, Department of General Surgery, Faculty of Medicine, Istanbul Okan University, Istanbul 34959, Turkey. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: MicroRNA-21 (miR-21) is one of the most widely studied oncogenic microRNAs and has been implicated in breast cancer progression, therapy resistance, and metastatic potential. However, its utility as a long-term prognostic biomarker in patients undergoing mastectomy remains insufficiently clarified. This study evaluated the prognostic significance of miR-21 expression in predicting overall and disease-free survival.

Methods

A retrospective cohort of 426 breast cancer patients who underwent mastectomy between 2010 and 2017 was analyzed. Tumor miR-21 expression was measured using quantitative real-time PCR and categorized as high or low based on cohort-derived thresholds. Long-term outcomes were assessed over a median follow-up of 112 months. Kaplan–Meier survival curves, log-rank tests, and multivariable Cox proportional hazards models were used to estimate associations between miR-21 levels and survival outcomes.

Results

High miR-21 expression was identified in 48.8% of cases. Patients with high miR-21 demonstrated significantly poorer overall survival (10-year OS: 61.4% vs. 82.7%; log-rank p < 0.001) and disease-free survival (10-year DFS: 54.9% vs. 78.3%; log-rank p < 0.001). In multivariable analysis, high miR-21 remained an independent predictor of decreased OS (HR = 2.18; 95% CI: 1.56–3.04) and DFS (HR = 2.44; 95% CI: 1.78–3.33).

Conclusions

Elevated miR-21 expression is a significant independent biomarker of adverse long-term prognosis in breast cancer patients undergoing mastectomy. Integrating miR-21 into postoperative risk stratification may improve individualized management strategies.

Schlagwörter

Stichwörter der Autor:innen

biomarkerbreast cancerdisease-free survivalmastectomymicroRNA-21overall survivalprognosis

Autor:innen und Institutionen

  • Surgical Oncology Unit, Department of General Surgery, Faculty of Medicine, Istanbul Okan University, Istanbul 34959, Turkey.
  • Department of Genetics, Faculty of Medicine, Istanbul Okan University, Istanbul 34959, Turkey.

ORCID-Profile: Kağan Gökçe, Mehrdad Sheikhvatan

Zitieren

APA

Gökçe, K., Üner, M., Adil, N., & Sheikhvatan, M. (2026). MicroRNA-21 Emerges as Key Prognostic Indicator After Breast Cancer Surgery. Journal of Clinical Medicine, 15(11), 4053. https://doi.org/10.3390/jcm15114053

Vancouver

Gökçe K, Üner M, Adil N, Sheikhvatan M. MicroRNA-21 Emerges as Key Prognostic Indicator After Breast Cancer Surgery. Journal of Clinical Medicine. 2026;15(11):4053. doi:10.3390/jcm15114053

BibTeX
@article{Gke2026,
  author = {Gökçe, Kağan and Üner, Murat and Adil, Nur and Sheikhvatan, Mehrdad},
  title = {MicroRNA-21 Emerges as Key Prognostic Indicator After Breast Cancer Surgery},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {4053},
  doi = {10.3390/jcm15114053}
}
Kostenlos starten →